Literature DB >> 35507356

Use of Machine Learning Consensus Clustering to Identify Distinct Subtypes of Black Kidney Transplant Recipients and Associated Outcomes.

Charat Thongprayoon1, Pradeep Vaitla2, Caroline C Jadlowiec3, Napat Leeaphorn4, Shennen A Mao5, Michael A Mao6, Pattharawin Pattharanitima7, Jackrapong Bruminhent8,9, Nadeen J Khoury10, Vesna D Garovic1, Matthew Cooper11, Wisit Cheungpasitporn1.   

Abstract

Importance: Among kidney transplant recipients, Black patients continue to have worse graft function and reduced patient and graft survival. Better understanding of different phenotypes and subgroups of Black kidney transplant recipients may help the transplant community to identify individualized strategies to improve outcomes among these vulnerable groups. Objective: To cluster Black kidney transplant recipients in the US using an unsupervised machine learning approach. Design, Setting, and Participants: This cohort study performed consensus cluster analysis based on recipient-, donor-, and transplant-related characteristics in Black kidney transplant recipients in the US from January 1, 2015, to December 31, 2019, in the Organ Procurement and Transplantation Network/United Network for Organ Sharing database. Each cluster's key characteristics were identified using the standardized mean difference, and subsequently the posttransplant outcomes were compared among the clusters. Data were analyzed from June 9 to July 17, 2021. Exposure: Machine learning consensus clustering approach. Main Outcomes and Measures: Death-censored graft failure, patient death within 3 years after kidney transplant, and allograft rejection within 1 year after kidney transplant.
Results: Consensus cluster analysis was performed for 22 687 Black kidney transplant recipients (mean [SD] age, 51.4 [12.6] years; 13 635 men [60%]), and 4 distinct clusters that best represented their clinical characteristics were identified. Cluster 1 was characterized by highly sensitized recipients of deceased donor kidney retransplants; cluster 2, by recipients of living donor kidney transplants with no or short prior dialysis; cluster 3, by young recipients with hypertension and without diabetes who received young deceased donor transplants with low kidney donor profile index scores; and cluster 4, by older recipients with diabetes who received kidneys from older donors with high kidney donor profile index scores and extended criteria donors. Cluster 2 had the most favorable outcomes in terms of death-censored graft failure, patient death, and allograft rejection. Compared with cluster 2, all other clusters had a higher risk of death-censored graft failure and death. Higher risk for rejection was found in clusters 1 and 3, but not cluster 4. Conclusions and Relevance: In this cohort study using an unsupervised machine learning approach, the identification of clinically distinct clusters among Black kidney transplant recipients underscores the need for individualized care strategies to improve outcomes among vulnerable patient groups.

Entities:  

Mesh:

Year:  2022        PMID: 35507356      PMCID: PMC9069346          DOI: 10.1001/jamasurg.2022.1286

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   16.681


  2 in total

1.  Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States.

Authors:  Charat Thongprayoon; Shennen A Mao; Caroline C Jadlowiec; Michael A Mao; Napat Leeaphorn; Wisit Kaewput; Pradeep Vaitla; Pattharawin Pattharanitima; Supawit Tangpanithandee; Pajaree Krisanapan; Fawad Qureshi; Pitchaphon Nissaisorakarn; Matthew Cooper; Wisit Cheungpasitporn
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

2.  Distinct Phenotypes of Kidney Transplant Recipients in the United States with Limited Functional Status as Identified through Machine Learning Consensus Clustering.

Authors:  Charat Thongprayoon; Caroline C Jadlowiec; Wisit Kaewput; Pradeep Vaitla; Shennen A Mao; Michael A Mao; Napat Leeaphorn; Fawad Qureshi; Pattharawin Pattharanitima; Fahad Qureshi; Prakrati C Acharya; Pitchaphon Nissaisorakarn; Matthew Cooper; Wisit Cheungpasitporn
Journal:  J Pers Med       Date:  2022-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.